Status: Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.
Participants needed: 50
Trial details
Age: 30-99Biological sex: AllType: ObservationalSponsor: InSightecUpdated: Mar 20, 2026Locations: 8
Eligibility criteria
Men and women, age 30 years and older [+3]